L7 | Resource Center
webinars + presentations
Join Vasu Rangadass, CEO & President at L7 Informatics, as he discusses achieving operational excellence in Life Sciences using digital
Explore the potential of "Informatics as a Service" in modern drug discovery, as it provides companies access to a range
Explore the advantages of utilizing a unified platform for managing decentralized manufacturing operations in the era of Industry 4.0. Discover
Explore the challenges and benefits of digitalizing cell and gene therapy laboratory workflows through case studies, revealing improvements in reproducibility,
Discover Tag.bio, a next-generation end-to-end data mesh platform that combines AI/machine learning algorithms with a federated computational layer. Learn how
In this recording, Vasu Rangadass, President and CEO at L7 Informatics, discusses how applying the 4th Industrial Revolution principles can
Vasu Rangadass, President and CEO at L7 Informatics, explores the potential of applying principles from the 4th Industrial Revolution and
After a brief speaker introduction from Jared Fine, Partner at Goodwin, Vasu Rangadass, Ph.D., President & CEO of L7 Informatics,
The automation of the entire laboratory workflow, from sample to insight, and the selection of the miRNA NGS assay development
The set-up of a successful bedside genomics program in a health system through digitalization and automation of rapid whole genome
The implementation of L7|ESP, a robust regulatory-compliant platform, to manage Gradalis' data for its process of manufacturing transfected immune-stimulated cells.
John F. Conway, Chief Visioneer Officer at 20/15 Visioneers gives his perspective on how selecting next-generation scientific software solutions built
A deep-dive into considerations for a better data provenance in the lab and the case for a holistic approach that
An in-depth analysis on the importance of integrating workflows and data management in a context of global pandemic. With Covid-19,
Gradalis chose L7's unified platform over other vendors to manage data for its process for manufacturing transfected immune-stimulated cells.
L7's Enterprise Science Platform (L7|ESP) enabled CSI-Dx to perfect their analytical and clinical validation processes, allowing very fast processing times
L7|ESP is a DATA+INTELLIGENCE platform that enables diagnostic organizations to use a single platform for registering and processing samples, running
Automate and improve research life-cycle processes by digitalizing experiment-to-insight.
Deliver superior service with faster turn-around by digitalizing order-to-report.
Streamline and automate the patient workflow by digitalizing diagnosis-to-results.
Our latest L7|ESP release, L7|ESP 3.2, focuses on improved performance stability to ensure fast operations. Additional release highlights include an
At L7 Informatics Inc. we believe collaboration is the key to scientific progress. That's why we developed the L7|HUB, a
Take a deeper dive into the features that set the L7 MES app as the right choice for pharmaceutical manufacturing.
In the fast-paced world of biotechnology, efficient sample management is crucial for laboratories to operate at their full potential. Embrace